Vir Biotechnology reports positive hepatitis delta trial data
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
| (NASDAQ: VIR) | Delayed: 9.96 -0.51 (4.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.47 | 52 Week High | $ | |||
| Open | $10.49 | 52 Week Low | $ | |||
| Day High | $10.49 | P/E | N/A | |||
| Day Low | $9.91 | EPS | $ | |||
| Volume | 1,735,553 | |||||
